PYXS pyxisoncology.com: Business Value

pyxisoncology.com (PYXS) - corporate logo

Pyxis Oncology, Inc. (PYXS) focuses on developing high-precision ADC drugs for the therapy of severe oncological pathologies and is currently in the clinical trial stage. The company's technology stack enables the delivery of toxic agents strictly to the site of the disease, overcoming tumor resistance. The current enterprise value stands at 220.14. This price chart illustrating value trends confirms the business's complete independence from economic cycles and macroeconomic shocks.

PYXS (Pyxis Oncology) Total Company Value history from 11/23/2025 to 10/29/2026

Pyxis Oncology - analytical breakdowns and key metrics (PYXS)

- price and consensus price forecast:
Market Price Pyxis Oncology Inc.|PYXS - Consensus Target
- market capitalization data:
Market Capitalization Pyxis Oncology|PYXS - Total Company Value
- book capitalization data:
Net Assets per Share Pyxis Oncology|PYXS - Company Book Value|Market-to-Book Ratio pyxisoncology.com|PYXS - Aggregate Company Assets
- debt and liquidity data:
Debt to Equity Ratio Pyxis Oncology, Inc.|PYXS - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Pyxis Oncology Inc.|PYXS - Company Debts|Debts to Book Value Pyxis Oncology|PYXS - Company Long-Term Debt|Company Short-Term Debt Pyxis Oncology
Fundamental valuation:Pyxis Oncology, Inc. (PYXS)
Original product of Pyxis

For Pyxis Oncology, Inc. (PYXS), high liquidity and confident management make the company's full operational valuation a key metric of investment attractiveness. This indicator sums market capitalization and liabilities, subtracting cash, which allows an investor to see the real cost of acquiring the business, stripped of temporary market fluctuations and excess cash.

Competitors of Pyxis Oncology, Inc. (PYXS)

IBRX - Total Enterprise Value|Immunocore PLC (IMCR) - Real Price to Acquire Entire Company|JANX: Business Value|Arcus Biosciences, Inc. - Total Company Value|ZYME (zymeworks.com) - Company Buyout Price|Total Company Value TNGX (Tango Therapeutics, Inc.)|Total Enterprise Value IOVA|Total Company Value Immatics Corp IMTX|Business Value Xencor Inc. (XNCR)|Compass Therapeutics - Enterprise Value|replimune.com - Real Price to Acquire Entire Company|LYEL (Lyell Immunopharma, Inc.) - Total Company Value|IPHA: Total Enterprise Value|cgen.com (CGEN) - Total Company Value|IOBT (IO Biotech Inc.) - Total Company Value|Total Company Value STRO (Sutro Biopharma, Inc.)|Total Enterprise Value minktherapeutics.com|HOWL: Enterprise Value|Full Takeover Company Value immixbio.com IMMX|ALXO: Real Price to Acquire Entire Company|CUE - Total Enterprise Value|Real Price to Acquire Entire Company PDS Biotechnology Corp (PDSB)|SONN - Value Adjusted for Debt and Cash|MAIA Biotechnology, Inc. - Enterprise Value|LIMN (Liminatus Pharma Inc.) - Company Buyout Price|Total Company Value LVTX|Real Price to Acquire Entire Company NXTC|Total Company Value LPTX (Leap Therapeutics, Inc.)|Real Price to Acquire Entire Company intensitytherapeutics.com INTS|Real Price to Acquire Entire Company SNSE (Sensei Biotherapeutics, Inc.)|Theriva Biologics Inc - Enterprise Value|Gritstone Bio (GRTS) - Total Company Value|KA: Business Value|Total Company Value NEXI|Total Enterprise Value Turnstone Biologics Corp.|Vaccinex - Real Price to Acquire Entire Company|Full Takeover Company Value Harpoon Therapeutics Inc (HARP)